The authors report the worsening of preexisting Raynaud's phenomenon during treatment of depression with a selective serotonin reuptake inhibitor, fluvoxamine.
Get full access to this article
View all access options for this article.
References
1.
Biondi ML, Marasini B., Bianchi E., et al: Plasma free and intraplatelet serotonin in patients with Raynaud's phenomenon. Int J Cardiol19:335-339, 1988.
2.
Arneklo-Nobin B., Elmer O., Akesson A., et al: Effect of long term ketanserin treatment on 5-HT levels, platelet aggregation and peripheral circulation in patients with Raynaud's phenomenon. Int Angiol7:19-25, 1988.
3.
Winkelmann RK , Goldyne ME, Linscheid RL, et al: Hypersensitivity of scleroderma cutaneous vascular smooth musc!e to 5-HT. Br J Dermatol95:51-56, 1976.
4.
Moulds Rfw, Iwanov V., Medcalf R., et al: The effects of platelet-derived contractile agents on human digital arteries. Clin Sci66:443-451, 1984.
5.
Roddie IC, Shepherd JT, Whelan RF, et al: The action of 5-HT on the blood vessels of the human hand and forearm. Br J Pharmacol10:445-450, 1955.
6.
Stranden E., Roald OK, Krohg K., et al: Treatment of Raynaud's phenomenon with the 5-HT2 receptor antagonist ketanserin. Br Med J285:1069-1071, 1982 .
7.
Ortiz J., Artigas F.: Effects of monoamine uptake inhibitors on extracellular and platelet 5-HT in rat blood: Different effects of clomipramine and fluoxetine. Br J Pharrnacol105:941-946, 1992.
8.
Celada P., Dolera M., Alvarez E., et al: Effects of acute and chronic treatment with fluvoxamine on extracellular and platelet serotonin in the blood of major depressive patients. Relationship to clinical improvement. J Affective Disorders25:243-250, 1992.
9.
Wigley EM, Wise RA, Siebold JR, et al: Intravenous iloprost infusion in patients with Raynaud's phenomenon secondary to systemic sclerosis. Ann Intern Med120:199-206, 1994.
10.
Berger M., Massardier A.: Aspects of treating depressive states in the very elderly with the combination of perfusions, antidepressants and medical care. ActualiesPsychiat (F) (5):71-79, 1976.
11.
Bolte MA, Avery D.: Case of fluoxetine-induced remission of Raynaud's phenomenon—a case report. Angiology44:161-163, 1993.
